Chapter title |
Prevention and treatment for epstein-barr virus infection and related cancers.
|
---|---|
Chapter number | 10 |
Book title |
Viruses and Human Cancer
|
Published in |
Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, January 2014
|
DOI | 10.1007/978-3-642-38965-8_10 |
Pubmed ID | |
Book ISBNs |
978-3-64-238964-1, 978-3-64-238965-8
|
Authors |
Françoise Smets, Etienne M Sokal, Etienne M. Sokal, Smets, Françoise, Sokal, Etienne M. |
Abstract |
Epstein-Barr virus (EBV) was the first herpes virus described as being oncogenic in humans. EBV infection is implicated in post-transplant lymphoproliferative diseases (PTLD) and several other cancers in non-immunocompromised patients, with more than 200,000 new cases per year. While prevention of PTLD is improving, mainly based on EBV monitoring and preemptive tapering of immunosuppression, early diagnosis remains the best current option for the other malignancies. Significant progress has been achieved in treatment, with decreased mortality and morbidity, but some challenges are still to face, especially for the more aggressive diseases. Possible prevention by EBV vaccination would be a more global approach of this public health problem, but further active research is needed before this goal could be reached. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 19 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 4 | 21% |
Student > Ph. D. Student | 4 | 21% |
Other | 2 | 11% |
Student > Postgraduate | 2 | 11% |
Student > Master | 1 | 5% |
Other | 3 | 16% |
Unknown | 3 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 26% |
Agricultural and Biological Sciences | 3 | 16% |
Nursing and Health Professions | 2 | 11% |
Environmental Science | 1 | 5% |
Computer Science | 1 | 5% |
Other | 3 | 16% |
Unknown | 4 | 21% |